(Q54429259)

29 May 2018

title

[Cutaneous manifestations of Lyme disease : Pitfalls in the serological diagnostic workup]. (English)

1 reference

29 May 2018

0 references

M Glatz

1

1 reference

29 May 2018

R R Müllegger

series ordinal

2

1 reference

29 May 2018

language of work or name

German

0 references

publication date

1 April 2017

1 reference

29 May 2018

published in

Die Dermatologie

1 reference

29 May 2018

volume

68

1 reference

29 May 2018

issue

4

1 reference

29 May 2018

page(s)

329-339

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/s00105-017-3952-1

exact match

0 references

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. nov.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Microbiological and serological diagnosis of Lyme borreliosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Skin manifestations of lyme borreliosis: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

The Clinical Assessment, Treatment, and Prevention of Lyme Disease, Human Granulocytic Anaplasmosis, and Babesiosis: Clinical Practice Guidelines by the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Lyme Disease Diagnosis: Serology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Two-Tiered Antibody Testing for Lyme Disease With Use of 2 Enzyme Immunoassays, a Whole-Cell Sonicate Enzyme Immunoassay Followed by a VlsE C6 Peptide Enzyme Immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Single-tier testing with the C6 peptide ELISA kit compared with two-tier testing for Lyme disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Antibodies against Borrelia burgdorferi sensu lato among Adults, Germany, 2008-2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Detection of Candidatus Neoehrlichia mikurensis, Borrelia burgdorferi sensu lato genospecies and Anaplasma phagocytophilum in a tick population from Austria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Clinical characteristics and treatment outcome of early Lyme disease in patients with microbiologically confirmed erythema migrans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Comparison of culture-confirmed erythema migrans caused by Borrelia burgdorferi sensu stricto in New York State and by Borrelia afzelii in Slovenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Correlation of Culture Positivity, PCR Positivity, and Burden of Borrelia burgdorferi Sensu Lato in Skin Samples of Erythema Migrans Patients with Clinical Findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Persistence of Borrelia burgdorferi in rhesus macaques following antibiotic treatment of disseminated infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

A Critical Appraisal of “Chronic Lyme Disease”

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Matrix metalloproteinase-10 is a target of T and B cell responses that correlate with synovial pathology in patients with antibiotic-refractory Lyme arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Ceftriaxone-induced immune hemolytic anemia as a life-threatening complication of antibiotic treatment of 'chronic Lyme disease'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00105-017-3952-1

Of ticks, mice and men: understanding the dual-host lifestyle of Lyme disease spirochaetes

21 January 2018

1 reference

12 December 2020

How accurate is a clinical diagnosis of erythema chronicum migrans? Prospective study comparing the diagnostic accuracy of general practitioners and dermatologists in an area where lyme borreliosis is endemic

1 reference

12 December 2020

Seronegative Lyme disease. Dissociation of specific T- and B-lymphocyte responses to Borrelia burgdorferi

1 reference

12 December 2020

Clinical and epidemiological findings for patients with erythema migrans. Comparison of cohorts from the years 1993 and 2000.

1 reference

12 December 2020

Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients

1 reference

12 December 2020

Clinical manifestations and diagnosis of lyme borreliosis

1 reference

12 December 2020

Effect of tick removal on transmission of Borrelia burgdorferi and Ehrlichia phagocytophila by Ixodes scapularis nymphs

1 reference

12 December 2020

Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans.

1 reference

12 December 2020

Persistence of immunoglobulin M or immunoglobulin G antibody responses to Borrelia burgdorferi 10-20 years after active Lyme disease

1 reference

12 December 2020

10.1007/S00105-017-3952-1

Identifiers

DOI

1 reference

29 May 2018

PubMed ID

28236088

1 reference

29 May 2018